Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Nora Franzen's publication output changed over time?
ScholarIQpublication output · 2019–2025
Output grew300% over the shown period — from 1 works in 2019 to 4 in 2025.
1
2
1
2
1
4
201920202022202320242025
What are the most-cited papers on Nora Franzen?
ScholarIQmost cited works
Impact of organ-on-a-chip technology on pharmaceutical R&D costs
Nora Franzen, Wim H. van Harten, Valesca P. Retèl, Peter Loskill, Janny van den Eijnden–van Raaij, Maarten J. IJzerman
S152068293. 2019171 CitationsOPEN ACCESS
Differences in time to patient access to innovative cancer medicines in six European countries
Julie M. Vancoppenolle, Nora Franzen, Simone N. Koole, Valesca P. Retèl, Wim H. van Harten
International Journal of Cancer. 202322 CitationsOPEN ACCESS
Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices
Nora Franzen, Valesca P. Retèl, Winnie Schats, Wim H. van Harten
JAMA Oncology. 202018 Citations
The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions
Michael Schlander, Wim H. van Harten, Valesca P. Retèl, Phu Duy Pham, Julie M. Vancoppenolle, Jasper Ubels, Olaya Seoane López, Camila Quirland, Felipe Rodríguez Maza, Eline Aas, Bernd Crusius, Agustín Escobedo, Nora Franzen, Jeanette Fuentes-Cid, Diego Hernández, K. Hernández-Villafuerte, Iva Kirac, Artus Paty, Thierry Philip, Sigbjørn Smeland, Richard Sullivan, Elena Vanni, Siniša Varga, Thomas Vermeulin, Rachel D. Eckford
The Lancet Oncology. 202417 CitationsOPEN ACCESS
Financial toxicity and socioeconomic impact of cancer in Europe
Julie M. Vancoppenolle, Nora Franzen, L. Azarang, T Juslin, Maria Krini, Tim Lubbers, Johanna Mattson, Didier Mayeur, Renée X. de Menezes, Jochen Schmitt, Florian Scotté, Olaya Seoane López, Tone Skaali, J Ubels, Michael Schlander, Valesca P. Retèl, Wim H. van Harten
ESMO Open. 202513 CitationsOPEN ACCESS
Related on ScholarIQ
Oncode Institute
Institution
Impact of organ-on-a-chip technology on pharmaceutical R&D costs
Paper
Differences in time to patient access to innovative cancer medicines in six European countries
Paper
Evidence Underlying Policy Proposals for Sustainable Anticancer Drug Prices
Paper
The socioeconomic impact of cancer on patients and their relatives: Organisation of European Cancer Institutes task force consensus recommendations on conceptual framework, taxonomy, and research directions
Paper
Financial toxicity and socioeconomic impact of cancer in Europe
Paper